How The Pulmonx (LUNG) Investment Story Is Shifting After Q4 And New Guidance [Yahoo! Finance]
Pulmonx Corporation (LUNG)
US:NASDAQ Investor Relations:
investor.prolunginc.com/investor-relations
Company Research
Source: Yahoo! Finance
Pulmonx is back in focus after analysts trimmed the price target from US$6 to US$5, while keeping a model fair value estimate of US$5.17 per share unchanged. This shift reflects a mixed read on the latest Q4 update, with some analysts encouraged by efforts to fix internal issues and others cautious about tempered expectations and execution risk. Ahead, you will see how this evolving narrative could matter for how you track Pulmonx and interpret future updates. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Pulmonx. What Wall Street Has Been Saying ?? Bullish Takeaways Canaccord, through analyst William Plovanic, kept a positive rating on Pulmonx even while trimming the price target to US$5, which signals continued confidence in the company at current levels. Canaccord highlighted that Q4 results were largely in line with expectations, which may give you some reference point that recent performance has not
Show less
Read more
Impact Snapshot
Event Time:
LUNG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUNG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUNG alerts
High impacting Pulmonx Corporation news events
Weekly update
A roundup of the hottest topics
LUNG
News
- How The Pulmonx (LUNG) Narrative Is Resetting Around Execution Risks And Fair Value Assumptions [Yahoo! Finance]Yahoo! Finance
- Pulmonx (LUNG) had its price target lowered by Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.MarketBeat
- Pulmonx (LUNG) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $14.00 price target on the stock.MarketBeat
- Pulmonx Corp (LUNG) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Sales Force ... [Yahoo! Finance]Yahoo! Finance
- Pulmonx Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
LUNG
Earnings
- 3/4/26 - Beat
LUNG
Analyst Actions
- 3/5/26 - Canaccord Genuity
LUNG
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/10/26 - Form S-8
- 3/10/26 - Form 10-K
- LUNG's page on the SEC website